Hikma Pharmaceuticals (HIK) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Hikma Pharmaceuticals

NOTE: This is based on 368 open tips for Hikma Pharmaceuticals (HIK)


Hikma Pharmaceuticals (HIK)
Latest Quote Price

1,991.00p

Hikma Pharmaceuticals (HIK)
Price Change (%)

0.76%


Latest Bid : 1,989.00p Latest Ask : 1,991.00p
High Today : 2,015.69p Low Today : 1,978.00p
This Years High : 2,340.00p This Years Low : 1,772.00p
Volume : 126,297 MKT Cap : £4400.11M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Hikma Pharmaceuticals (HIK) Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Hikma Pharmaceuticals (HIK) Latest Tips

Type Tipster SectorScore Start date Performance
Equal Weight Barclays Premium Only 2025-06-09 05:42:00 09/06/2025 -6.17%
Buy Jefferies Premium Only 2025-06-03 05:04:00 03/06/2025 -7.40%
Buy Russ Mould Premium Only 2025-05-27 05:00:00 27/05/2025 -5.28%
Outperform RBC Capital Premium Only 2025-05-20 05:48:00 20/05/2025 -3.91%
Outperform Exane Premium Only 2025-05-14 06:18:00 14/05/2025 1.22%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Hikma Pharmaceuticals (HIK) Active Short Positions

Fund Manager Position Date
Marshall Wace LLP 0.69% 09/07/2025
AQR Capital Management, LLC 0.5% 12/05/2025

See more short positions...


Latest Bid : 1,989.00p Latest Ask : 1,991.00p
High Today : 2,015.69p Low Today : 1,978.00p
This Years High : 2,340.00p This Years Low : 1,772.00p
Volume : 126,297 MKT Cap : £4400.11M

Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Hikma Pharmaceuticals Tips

Type Tipster SectorScore Start date Performance
Equal Weight Barclays Premium Only 2025-06-09 05:42:00 09/06/2025 -6.17%
Buy Jefferies Premium Only 2025-06-03 05:04:00 03/06/2025 -7.40%
Buy Russ Mould Premium Only 2025-05-27 05:00:00 27/05/2025 -5.28%
Outperform RBC Capital Premium Only 2025-05-20 05:48:00 20/05/2025 -3.91%
Outperform Exane Premium Only 2025-05-14 06:18:00 14/05/2025 1.22%